{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:17:32Z","timestamp":1791613052028,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174388"],"award-info":[{"award-number":["82174388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.waojou.2025.101072","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T08:02:30Z","timestamp":1748937750000},"page":"101072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Allergic-related skin diseases: Global disease burden from 1990 to 2021 and future trends"],"prefix":"10.1016","volume":"18","author":[{"given":"Xiao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangning","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.waojou.2025.101072_bib1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaip.2024.03.015","article-title":"The prevalence of IgE-Mediated food allergy and other allergic diseases in the first 10 years: the population-based, longitudinal HealthNuts study","volume":"12","author":"Peters","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.waojou.2025.101072_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02866-2021","article-title":"The burden of asthma, hay fever and eczema in children in 25 countries: GAN phase I study","volume":"60","author":"Garc\u00eda-Marcos","year":"2022","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.waojou.2025.101072_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2024.02.025","article-title":"Relationships between lung function, allergy, and wheezing in urban children","volume":"154","author":"Konno-Yamamoto","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2025.101072_bib4","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.24050","article-title":"A retrospective cohort study on the comorbidity in 19,264 Chinese patients of different ages with urticaria","volume":"104","author":"Xiao","year":"2024","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.waojou.2025.101072_bib5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jaip.2024.04.048","article-title":"How to prevent atopic dermatitis (Eczema) in 2024: theory and evidence","volume":"12","author":"Chu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2025.101072_bib6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/all.16092","article-title":"Skin, gut, and lung barrier: physiological interface and target of intervention for preventing and treating allergic diseases","volume":"79","author":"Berni Canani","year":"2024","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2025.101072_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaci.2024.02.005","article-title":"Mast cell-sensory neuron crosstalk in allergic diseases","volume":"153","author":"Bao","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2025.101072_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2025.101072_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (Eczema) guidelines: 2023 American academy of allergy, asthma and immunology\/american college of allergy, asthma and immunology joint task force on practice parameters GRADE- and institute of medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.waojou.2025.101072_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12195","article-title":"Clinical review: the suggested management pathway for urticaria in primary care","volume":"12","author":"Ryan","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2025.101072_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/bjd.16248","article-title":"Prevalence of skin disease in a population-based sample of adults from five European countries","volume":"178","author":"Svensson","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2025.101072_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/ddg.14734","article-title":"German S1 guideline: contact dermatitis","volume":"20","author":"Dickel","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.waojou.2025.101072_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105282","article-title":"Allergic contact dermatitis: from pathophysiology to development of new preventive strategies","volume":"162","author":"Brites","year":"2020","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.waojou.2025.101072_bib14","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/all.15807","article-title":"Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"78","author":"Shin","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2025.101072_bib15","doi-asserted-by":"crossref","DOI":"10.2196\/50114","article-title":"Burden of and trends in urticaria globally, regionally, and nationally from 1990 to 2019: systematic analysis","volume":"9","author":"Liu","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"10440","key":"10.1016\/j.waojou.2025.101072_bib16","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"10440","key":"10.1016\/j.waojou.2025.101072_bib17","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2025.101072_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-020-00915-0","article-title":"Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study","volume":"13","author":"Deng","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.waojou.2025.101072_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.740800","article-title":"Global burden of respiratory diseases attributable to ambient particulate matter pollution: findings from the global burden of disease study 2019","volume":"9","author":"Wu","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.waojou.2025.101072_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1216924","article-title":"Current status, trends, and predictions in the burden of silicosis in 204 countries and territories from 1990 to 2019","volume":"11","author":"Yi","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.waojou.2025.101072_bib22","article-title":"Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: an analysis and comparison","volume":"22doi","author":"Wang","year":"2024","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.waojou.2025.101072_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jad.2024.07.098","article-title":"Global burden of major depressive disorders attributable to intimate partner violence against women: Magnitude, temporal trends, and regional inequalities","volume":"363","author":"Hu","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.waojou.2025.101072_bib24","series-title":"Handbook on Health Inequality Monitoring: With a Special Focus on low-and middle-income Countries","year":"2023"},{"issue":"10","key":"10.1016\/j.waojou.2025.101072_bib25","doi-asserted-by":"crossref","first-page":"e1388","DOI":"10.1016\/S2214-109X(19)30360-2","article-title":"Rheumatic heart disease burden, trends, and inequalities in the americas, 1990-2017: a population-based study","volume":"7","author":"Ordunez","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1186\/s12889-024-19142-0","article-title":"Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib27","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1186\/s12889-024-18943-7","article-title":"Notable dysthymia: evolving trends of major depressive disorders and dysthymia in China from 1990 to 2019, and projections until 2030","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.waojou.2025.101072_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.18176\/jiaci.0983","article-title":"The multiple trajectories of the allergic March","volume":"34","author":"de Las Vecillas","year":"2024","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2025.101072_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081841","article-title":"Biologic and small molecule therapy in atopic dermatitis","volume":"12","author":"Shergill","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.waojou.2025.101072_bib30","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/all.16108","article-title":"Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years","volume":"79","author":"Guttman-Yassky","year":"2024","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2025.101072_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2024.05.029","article-title":"Reduced atopic March risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: a population-based cohort study","volume":"91","author":"Lin","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.waojou.2025.101072_bib32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.16009","article-title":"Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs","volume":"79","author":"M\u00fcller","year":"2024","journal-title":"Allergy"},{"issue":"10246","key":"10.1016\/j.waojou.2025.101072_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(20)30732-7","article-title":"Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"396","author":"Simpson","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.waojou.2025.101072_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","article-title":"Efficacy and safety of Lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial","volume":"156","author":"Guttman-Yassky","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.waojou.2025.101072_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/cea.14558","article-title":"Global, regional and national burden of paediatric atopic dermatitis: a trend and geographic inequalities analysis","author":"Cao","year":"2024","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"10.1016\/j.waojou.2025.101072_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/exd.13769","article-title":"The role of environmental factors in allergy: a critical reappraisal","volume":"27","author":"Gilles","year":"2018","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2025.101072_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11882-024-01141-1","article-title":"Environmental interventions for preventing atopic diseases","volume":"24","author":"Pfirrman","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.waojou.2025.101072_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.944365","article-title":"Cutaneous dysbiosis May amplify barrier dysfunction in patients with atopic dermatitis","volume":"13","author":"Hammond","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cea.13519","article-title":"Food-induced anaphylaxis in infancy compared to preschool age: a retrospective analysis","volume":"50","author":"Pouessel","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2025.101072_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11882-024-01147-9","article-title":"The role of the environment in allergic skin disease","volume":"24","author":"Faraz","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.waojou.2025.101072_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.anai.2019.02.003","article-title":"Trends in hospitalizations related to anaphylaxis, angioedema, and urticaria in the United States","volume":"122","author":"Shrestha","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2025.101072_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.166755","article-title":"Associations between long-term exposure to PM(2.5) chemical constituents and allergic diseases: evidence from a large cohort study in China","volume":"904","author":"Feng","year":"2023","journal-title":"Sci Total Environ"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/cea.14015","article-title":"Relationship between local weather, air pollution and hospital attendances for urticaria in children: time stratified analysis of 12,002 cases","volume":"52","author":"Choo","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2025.101072_bib44","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1111\/ajd.13283","article-title":"Dietary habits in Japanese patients with chronic spontaneous urticaria","volume":"61","author":"Matano","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.waojou.2025.101072_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5414\/ALX02554E","article-title":"Substantial psychosocial impairments in patients with chronic urticaria are associated with delayed referral to urticaria centers, non-academic treatments, and dietary changes","volume":"9","author":"Zarnowski","year":"2025","journal-title":"Allergol Select"},{"issue":"3","key":"10.1016\/j.waojou.2025.101072_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.iac.2021.04.005","article-title":"Epidemics of dermatitis","volume":"41","author":"Baghchechi","year":"2021","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/all.15538","article-title":"Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases","volume":"78","author":"Pavel","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2025.101072_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153679","article-title":"Topical treatment with mastic (resin from Pistacia lentiscus) elicits anti-inflammatory and anti-pruritic responses by modulating keratinocyte activation in a mouse model of allergic dermatitis","volume":"91","author":"Kishimoto","year":"2021","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.waojou.2025.101072_bib49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/cod.13959","article-title":"Dysregulation of the epithelial barrier by environmental and other exogenous factors","volume":"85","author":"Mitamura","year":"2021","journal-title":"Contact Dermat"},{"issue":"Suppl 4","key":"10.1016\/j.waojou.2025.101072_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jdv.15253","article-title":"Gerontodermatology: the fragility of the epidermis in older adults","volume":"32","author":"Katoh","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cod.14428","article-title":"Allergic contact dermatitis to footwear in Thailand: prevalence, clinical characteristics and common allergens","volume":"90","author":"Chaiyabutr","year":"2024","journal-title":"Contact Dermat"},{"issue":"5","key":"10.1016\/j.waojou.2025.101072_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/cod.14403","article-title":"Prevalence and causative allergens of contact cheilitis in Thailand","volume":"89","author":"Kanokrungsee","year":"2023","journal-title":"Contact Dermat"},{"issue":"9","key":"10.1016\/j.waojou.2025.101072_bib53","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.jaip.2024.04.052","article-title":"Comorbid scenarios in contact dermatitis: atopic dermatitis, irritant dermatitis, and extremes of age","volume":"12","author":"Yu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"17","key":"10.1016\/j.waojou.2025.101072_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179281","article-title":"Autoimmune mast cell activation test as a diagnostic tool in chronic spontaneous urticaria","volume":"25","author":"Koren","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.waojou.2025.101072_bib55","first-page":"Cd011224","article-title":"Leukotriene receptor antagonists for eczema","volume":"10","author":"Ferguson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.waojou.2025.101072_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"10478","key":"10.1016\/j.waojou.2025.101072_bib57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2025.101072_bib58","article-title":"Race and appointment availability influence continuity of care for chronic inflammatory skin disease: a cross-sectional study of United States practice data","author":"Nicholas","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455125000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455125000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:33:30Z","timestamp":1762598010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455125000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1939455125000493"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2025.101072","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic-related skin diseases: Global disease burden from 1990 to 2021 and future trends","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2025.101072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"101072"}}